3.2
Impact Factor
Volume 17 (1); 2026
Research Papers
Loss of CDKN2A/B is a Hallmark of RTK II Glioblastomas
Celina K. Langwieder, Dorothee Hölzl, Georg Hutarew, Hans U. Schlicker, Beate Alinger-Scharinger, Christoph Schwartz, Karl Sotlar, Theo F. J. Kraus
J. Cancer 2026; 17(1): 1-9. doi:10.7150/jca.122609
Full text
PDF
The Role of Inflammatory Biomarkers in PIPAC: Predicting Survival and Treatment Completion in Patients with Peritoneal Metastasis
Signe Roensholdt, Martin Graversen, Sönke Detlefsen, Claus Fristrup, Per Pfeiffer, Michael Bau Mortensen
J. Cancer 2026; 17(1): 10-20. doi:10.7150/jca.123687
Full text
PDF
Identification of key ferroptosis-related targets in colorectal cancer: A transcriptomics-driven study via machine learning and AUcell analysis of single-cell RNA-sequencing
Zhiqiang Liang, Zehui Hou, Zhuomin Yu, Bing Zeng, Fang Li, Jingjing Wu, Yingru Li, Zhipeng Jiang
J. Cancer 2026; 17(1): 32-48. doi:10.7150/jca.114522
Full text
PDF
Molecular Signature of Cisplatin Resistance in Ovarian Cancer Identifies Therapeutic Opportunities for Re-sensitization
Mahmoud Mansour, Sabrina van Ginkel, Maaz Alata, Ibrahim Bani, Isra Elhussin
J. Cancer 2026; 17(1): 49-58. doi:10.7150/jca.124252
Full text
PDF
Reviews
Biomarkers for Recurrence and Prognosis in Metastatic Urothelial Cancer: Emerging Clinical Applications
Alicia Sánchez Cendra, Linda Rocio Ospino, Leonel Pekarek, Yumna Dbouk, Sami Chnaiker, Ana Luengo, Tania Villamor, Amalia Corralo, Raul Diaz-Pedrero, Laura Lopez-Gonzalez, Miguel A Saez, Majd N Michael Alhaddadin, María Belén Alonso-Bartolome, Carlos Casanova-Martín, Melchor Alvarez-Mon, Leonor Garcia Rodriguez, Silvestra Barrena-Blázquez, Miguel A Ortega
J. Cancer 2026; 17(1): 21-31. doi:10.7150/jca.123907
Full text
PDF
Cancer Cell Dormancy and Chemotherapy Resistance
Jingxian Hu, Wei Zhou, Ying Zhao, Peiran Li, Zhenying Zhao, Wei Wang, Wenhong Wang, Yijia Wang
J. Cancer 2026; 17(1): 59-73. doi:10.7150/jca.123742
Full text
PDF